Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose S-ketamine for Postpartum Depression Prevention
NCT04414943Completed
- Sponsor
- Peking University First Hospital
- Start
- Jun 2020
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in postpartum depression (PPD) comparing S-ketamine group with Placebo group (2 arms). Primary endpoint: Incidence of depression at 42 days postpartum. Started Jun 2020; status: completed.
02
Drugs
esketamine
03
Conditions
postpartum depression (PPD)
Beyond the preview
Go deeper on NCT04414943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04414943.